Clal Insurance Enterprises Holdings Ltd - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Clal Insurance Enterprises Holdings Ltd ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$696
-98.4%
45,000
-98.4%
0.01%
-98.1%
Q2 2023$43,651
-39.3%
2,778,558
-36.4%
0.52%
-51.5%
Q1 2023$71,943
+5.6%
4,365,5000.0%1.08%
+5.4%
Q4 2022$68,102
-99.9%
4,365,500
+0.6%
1.02%
+32.2%
Q3 2022$56,296,000
+130.4%
4,340,500
+149.4%
0.77%
+137.8%
Q2 2022$24,437,0001,740,5000.32%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders